Comparisons of regular and on-demand regimen of PED5-Is in the treatment of ED after nerve-sparing radical prostatectomy for Prostate Cancer

Phosphodiesterase type-5 inhibitors (PDE5-Is) have been recommended as first line therapy for erectile dysfunction for patients received nerve-sparing radical prostatectomy for prostate cancer. We examed the efficiency of PDE5-Is and considered the optimal application. Systematic search of PubMed, E...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Shi., Tang, Zhuang, Deng, Linghui, Liu, Liangren, Han, Ping, Yang, Lu, Wei, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017160/
https://www.ncbi.nlm.nih.gov/pubmed/27611008
http://dx.doi.org/10.1038/srep32853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017160/
https://www.ncbi.nlm.nih.gov/pubmed/27611008
http://dx.doi.org/10.1038/srep32853

Ejemplares similares